­
­
­
­

Inventi Impact: Preventive & Social Medicines

Articles

  • Inventi:hpsm/22426/17
    Gaps in the Continuum of HIV Care: Long Pretreatment Waiting Time between HIV Diagnosis and\nAntiretroviral Therapy Initiation Leads to Poor Treatment Adherence and Outcomes
    01-Jan-1970 Research 2017 : April - June
    Shu Su, Shifu Li, Shunxiang Li, Liangmin Gao, Ying Cai, Jincui Fu, Chunyuan Guo, Jun Jing, Liang Chen, Limin Mao, Feng Cheng, Lei Zhang

    Background. Criteria for antiretroviral treatment (ART) were adjusted to enable early HIV treatment for people living HIV/AIDS\n(PLHIV) in China in recent years. This study aims to determine how pretreatment waiting time after HIV confirmation affects\nsubsequent adherence and outcomes over the course of treatment. Methods. A retrospective observational cohort study was\nconducted using treatment data from PLHIV in Yuxi, China, between January 2004 and December 2015. Results. Of 1,663\nparticipants, 348 were delayed testers and mostly initiated treatment within 28 days. In comparison, 1,315 were nondelayed testers\nand the median pretreatment waiting time was 599 days, but it significantly declined over the study period. Pretreatment CD4\nT-cell count drop (every 100 cells/mm3) contributed slowly in CD4 recovery after treatment initiation (8% less,

    How to Cite this Article
    CC Compliant Citation: Shu Su, Shifu Li, Shunxiang Li, et al., â??Gaps in the Continuum of HIV Care: Long Pretreatment Waiting Time\nbetween HIV Diagnosis and Antiretroviral Therapy Initiation Leads to Poor Treatment Adherence and Outcomes,â? BioMed Research\nInternational, vol. 2016, Article ID 2648923, 8 pages, 2016. doi:10.1155/2016/2648923, http://creativecommons.org/licenses/by/4.0/.
    Download Full Text